Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 15 studies | 33% ± 13% | |
peripheral blood | 14 studies | 30% ± 10% | |
brain | 9 studies | 31% ± 10% | |
intestine | 8 studies | 31% ± 14% | |
eye | 8 studies | 32% ± 15% | |
kidney | 7 studies | 28% ± 8% | |
liver | 6 studies | 36% ± 20% | |
lymph node | 5 studies | 37% ± 13% | |
pancreas | 4 studies | 43% ± 16% | |
bone marrow | 4 studies | 22% ± 6% | |
uterus | 4 studies | 38% ± 17% | |
breast | 4 studies | 33% ± 6% | |
placenta | 3 studies | 34% ± 7% | |
adrenal gland | 3 studies | 30% ± 11% | |
prostate | 3 studies | 28% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 9714.70 | 1445 / 1445 | 100% | 221.15 | 183 / 183 |
liver | 100% | 6067.20 | 226 / 226 | 100% | 272.48 | 406 / 406 |
ovary | 100% | 8983.22 | 180 / 180 | 100% | 244.53 | 430 / 430 |
skin | 100% | 11308.23 | 1809 / 1809 | 100% | 418.04 | 472 / 472 |
stomach | 100% | 7424.28 | 359 / 359 | 100% | 263.57 | 286 / 286 |
breast | 100% | 8005.00 | 459 / 459 | 100% | 427.29 | 1117 / 1118 |
prostate | 100% | 7718.08 | 245 / 245 | 100% | 297.71 | 501 / 502 |
uterus | 100% | 9342.40 | 170 / 170 | 100% | 351.10 | 458 / 459 |
lung | 100% | 6941.57 | 577 / 578 | 100% | 289.68 | 1153 / 1155 |
brain | 100% | 6893.48 | 2630 / 2642 | 100% | 262.91 | 705 / 705 |
intestine | 100% | 9177.94 | 966 / 966 | 99% | 300.39 | 524 / 527 |
thymus | 100% | 7083.14 | 653 / 653 | 99% | 200.38 | 601 / 605 |
bladder | 100% | 10199.48 | 21 / 21 | 99% | 322.62 | 500 / 504 |
pancreas | 100% | 5692.65 | 327 / 328 | 99% | 214.09 | 177 / 178 |
adrenal gland | 100% | 13501.76 | 258 / 258 | 97% | 237.59 | 224 / 230 |
kidney | 100% | 7699.99 | 89 / 89 | 97% | 159.60 | 877 / 901 |
adipose | 100% | 8037.26 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 594.12 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 434.60 | 29 / 29 |
muscle | 100% | 8731.72 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 7923.41 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 257.07 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 156.32 | 1 / 1 |
blood vessel | 100% | 8039.39 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 97% | 6406.34 | 832 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 91% | 7073.42 | 848 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007339 | Biological process | binding of sperm to zona pellucida |
GO_1904871 | Biological process | positive regulation of protein localization to Cajal body |
GO_0061077 | Biological process | chaperone-mediated protein folding |
GO_1904874 | Biological process | positive regulation of telomerase RNA localization to Cajal body |
GO_1904851 | Biological process | positive regulation of establishment of protein localization to telomere |
GO_0006457 | Biological process | protein folding |
GO_0050821 | Biological process | protein stabilization |
GO_0032212 | Biological process | positive regulation of telomere maintenance via telomerase |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005874 | Cellular component | microtubule |
GO_0005832 | Cellular component | chaperonin-containing T-complex |
GO_0002199 | Cellular component | zona pellucida receptor complex |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0044297 | Cellular component | cell body |
GO_0044183 | Molecular function | protein folding chaperone |
GO_0051082 | Molecular function | unfolded protein binding |
GO_0140662 | Molecular function | ATP-dependent protein folding chaperone |
GO_0005524 | Molecular function | ATP binding |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0016887 | Molecular function | ATP hydrolysis activity |
Gene name | CCT3 |
Protein name | T-complex protein 1 subunit gamma (CCT-gamma) T-complex protein 1 subunit gamma Chaperonin containing TCP1 subunit 3 T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma) (hTRiC5) |
Synonyms | CCTG TRIC5 |
Description | FUNCTION: Component of the chaperonin-containing T-complex (TRiC), a molecular chaperone complex that assists the folding of proteins upon ATP hydrolysis . The TRiC complex mediates the folding of WRAP53/TCAB1, thereby regulating telomere maintenance . As part of the TRiC complex may play a role in the assembly of BBSome, a complex involved in ciliogenesis regulating transports vesicles to the cilia . The TRiC complex plays a role in the folding of actin and tubulin (Probable). . |
Accessions | ENST00000295688.8 [P49368-1] ENST00000478640.6 P49368 ENST00000446905.5 E9PRM9 ENST00000496684.6 ENST00000415548.1 ENST00000472765.6 E9PRN0 Q5SZW8 ENST00000413555.5 ENST00000533194.5 E9PRC8 Q5SZX6 Q5SZX9 E9PM09 ENST00000368259.6 [P49368-2] ENST00000368258.7 ENST00000368262.7 E9PQ35 B4DUR8 |